106
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models

, , , , , , , , & show all
Pages 1261-1279 | Published online: 31 Mar 2016

References

  • American Cancer Society [homepage on the internet]AtlantaAmerican Cancer Society [updated October 2015; cited October 2015]. Available from: http://www.cancer.org/indexAccessed October 2015
  • Cancer Research UK [homepage on the internet]LondonCancer Research UK [updated June 2015; cited June 2015]. Available from: http://www.cancerresearchuk.org/Accessed June 2015
  • National Cancer Institute [homepage on the internet]RockvilleNational Cancer Institute – NIH [updated April 2015; cited April 2015]. Available from: http://www.cancer.gov/Accessed April 2015
  • BagloleCJRayDMBernsteinSHMore than structural cells, fibroblasts create and orchestrate the tumor microenvironmentImmunol Invest2006353–429732516916756
  • MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
  • BraeuerRRWatsonIRWuCJWhy is melanoma so metastatic?Pigment Cell Melanoma Res2014271193624106873
  • AsciertoPAGrimaldiAMAndersonACFuture perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th–8th 2013J Transl Med20141227725348889
  • BeiDMengJYouanBBEngineering nanomedicines for improved melanoma therapy: progress and promisesNanomedicine (Lond)2010591385139921128721
  • LiJWangYLiangRRecent advances in targeted nanoparticles drug delivery to melanomaNanomedicine201511376979425555352
  • HwangTLLeeWRHuaSCFangJYCisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro, cytotoxicity and in vivo, intratumor drug accumulation against melanomasJ Dermatol Sci2007461112017267180
  • BedikianAYVardeleonASmithTCampbellSNamdariRPharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patientsJ Clin Pharmacol200646772773716809798
  • BanciuMMetselaarJMSchiffelersRMStormGLiposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing miceJ Steroid Biochem Mol Biol20081111–210111018602825
  • MitrusISochanikACichonTSzalaSCombination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16–F10 tumorsActa Biochim Pol200956116116519287800
  • VannucciLFiserovaASadalapureKEffects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivoInt J Oncol200323228529612851676
  • SchilrreffPMundiña-WeilenmannCRomeroELMorillaMJSelective cytotoxicity of PAMAM G5 core – PAMAM G2.5 shell tecto-dendrimers on melanoma cellsInt J Nanomed2012741214133
  • LiaoJWangCWangYLuo F; QianFRecent advances in formation, properties, and applications of polymersomesCurr Pharm Des201218233432344122632981
  • PegoraroCCecchinDGraciaLSEnhanced drug delivery to melanoma cells using PMPC-PDPA polymersomesCancer Lett2013334232833723402813
  • ChaudhuriPSoniSSenguptaSSingle-walled carbon nanotube conjugated chemotherapy exhibits increased therapeutic index in melanomaNanotechnology201021202510219955607
  • ChenJShaoRZhangXDChenCApplications of nanotechnology for melanoma treatment, diagnosis, and theranosticsInt J Nanomed2013826772688
  • FinkWZimpfer-RechnerCThoelkeAClinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanomaOnkologie200427654054415591712
  • HershEMO’DaySJRibasAA phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanomaCancer2010116115516319877111
  • MontanaMDucrosCVerhaeghePTermeTVanellePRathelotPAlbumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancersJ Chemother2011232596621571619
  • RamishettiSHuangLIntelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapyTher Deliv20123121429144523323560
  • FrankLAContriRVBeckRCPohlmannARGuterresSSImproving drug biological effects by encapsulation into polymeric nanocapsulesWiley Interdiscip Rev Nanomed Nanobiotechnol20157562363925641603
  • PohlmannARFonsecaFNPaeseKPoly(ε-caprolactone) microcapsules and nanocapsules in drug deliveryExpert Opin Drug Deliv201310562363823387432
  • PisanoMPagnanGLoiMAntiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cellsMol Cancer20076811217199893
  • JaganathanSKSupriyantoEAntiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cellsMolecules20121766290630422634840
  • CourrègesMCBenenciaFIn vitro antiphagocytic effect of basil oil on mouse macrophagesFitoterapia200273536937412165330
  • KalembaDKunickaAAntibacterial and antifungal properties of essential oilsCurr Med Chem2003101081382912678685
  • BragaPSSassoMDCuliciMAlfieriMEugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicansFitoterapia200778639640017590533
  • KaurGAtharMAlamMSEugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosisMol Carcinog201049329030120043298
  • ParkBSSongYSYeeSBPhospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosisApoptosis20051019320015711935
  • ShinSHParkJHKimGCParkBSGilYGKimCHThe mechanism of apoptosis induced by eugenol in human osteosarcoma cellsJ Korean Oral Maxillofac Surg20073312027
  • OkadaNHirataAMurakamiYShojiMSakagamiHFujisawaSInduction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression by eugenol-related compoundsAnticancer Res20052553263326916101137
  • YooCBHanKTChoKSEugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cellsCancer Lett20052251415215922856
  • JaganathanSKMazumdarAMondheDMandalMApoptotic effect of eugenol in human colon cancer cell linesCell Biol Int201135660761521044050
  • GhoshRNadimintyNFitzpatrickJEAlworthWLSlagaTJKumarAPEugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activityJ Biol Chem200528075812581915574415
  • JagerEVenturiniCGPolettoFSSustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface areaJ Biomed Nanotechnol20095113014020055116
  • LiY-HSunZ-HZhengPDetermination of vanillin, eugenol and isoeugenol by RP-HPLCChromatographia20046011/12709713
  • International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human useICH Harmonized Tripartite Guideline – Guideline for Good Clinical Practice – E6(R1) Current Step 4 Version6101996
  • DrewesCCDiasRYBrancoVGPost-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cellsToxicon201510111025912945
  • BaylisCVallancePMeasurement of nitrite and nitrate levels in plasma and urine – what does this measure tell us about the activity of the endogenous nitric oxide system?Curr Opin Nephrol Hypertens19987159629442364
  • DegakiTLDemasiMAASogayarMCOverexpression of Nrp/b (nuclear restrict protein in brain) suppresses the malignant phenotype in the C6/ST1 glioma cell lineJ Steroid Biochem Mol Biol20091174–510711619682578
  • OverwijkWWRestifoNPB16 as a mouse model for human melanomaCurr Protoc Immunol2001 Chapter 20:Unit 20.1
  • VenturiniCGJägerEOliveiraCPFormulation of lipid core nanocapsulesColloids Surf A Physicochem Eng Aspects20113751–3200208
  • OliveiraCVenturiniCGDonidaBPolettoSFGuterresSSPohlmannARAn algorithm to determinate the mechanism of drug distribution in lipid-core nanocapsule formulationsSoft Matter20139411411150
  • GuterresSSWeissVde Luca FreirasLPohlmannARInfluence of benzyl benzoate as oil core on the physicochemical properties of spray-dried powders from polymeric nanocapsules containing indomethacinDrug Deliv20007419519911195425
  • FielLADesenvolvimento de nanocápsulas de núcleo lipídico com uso potencial no tratamento de tumores sólidos [Lipid core nanocapsules: The influence of the nanostructure and surface area to the biological response in vitro]. [thesis]AccraFederal University of Rio Grande do Sul2013 Portuguese
  • KreuterJApplication of nanoparticles for the delivery of drugs to the brainInt Congr Ser200512778594
  • JornadaDSFriedrichRBFerrariniSLipid-core nanocapsules: reducing the aqueous phase volume to increase encapsulation efficiency and to reduce the energy and time consuming of the production processJ Colloid Sci Biotechnol2015417985
  • ZhaoFZhaoYLiuYCellular uptake, intracellular trafficking, and cytotoxicity of nanomaterialsSmall20117101322133721520409
  • FielLAContriRVBicaJFLabeling the oily core of nanocapsules and lipid-core nanocapsules with a triglyceride conjugated to a fluorescent dye as a strategy to particle tracking in biological studiesNanoscale Res Lett20149123324936156
  • PolettoFSFielLALopesMVFluorescent-labeled poly(ε-caprolactone) lipid-core nanocapsules: synthesis, physicochemical properties and macrophage uptakeJ Colloid Sci Biotechnol201218998
  • CharãoMFBaierleMGauerBProtective effects of melatonin-loaded lipid-core nanocapsules on paraquat-induced cytotoxicity and genotoxicity in a pulmonary cell lineMutat Res Genet Toxicol Environ Mutagen201578478519
  • DanilovAVDanilovaOVHuberBTCell cycle control and adhesion signaling pathways in the development of metastatic melanomaCancer Metastasis Rev200827470771418496651
  • SulzmaierFJJeanCSchlaepferDDFAK in cancer: mechanistic findings and clinical applicationsNat Rev Cancer201414959861025098269
  • WinkDAVodovotzYLavalJLavalFDewhirstMWMitchellJBThe multifaceted roles of nitric oxide in cancerCarcinogenesis19981957117219635855
  • FukumuraDKashiwagiSJainRKThe role of nitric oxide in tumour progressionNat Rev Cancer20066752153416794635
  • BurkeAJSullivanFJGilesFJGlynnSAThe yin and yang of nitric oxide in cancer progressionCarcinogenesis201334350351223354310
  • PfeifferSLeopoldESchmidtKBrunnerFMayerBInhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginineBr J Pharmacol19961186143314408832069
  • BuenoKAdorneMDJornadaDSda FonsecaFNGuterresSSPohlmannARIn vivo gastroprotective effect of nanoparticles: influence of chemical composition and volume fractionCurr Pharm Des201319417294730023489206
  • KülkampICRabeloBDBerlitzSJNanoencapsulation improves the in vitro antioxidant activity of lipoic acidJ Biomed Nanotechnol20117459860721870465
  • BenderEACavalcanteMFAdorneMDNew strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(-)-functionalized nanocapsulesPharm Res201431112975298724805278
  • BauerGIncreasing the endogenous NO level causes catalase inactivation and reactivation of intercellular apoptosis signaling specifically in tumor cellsRedox Biol2015635337126342455
  • VenzaMVisalliMBeninatiCDe GaetanoGVTetiDVenzaICellular mechanisms of oxidative stress and action in melanomaOxid Med Cell Longev2015201548178226064422
  • PiskounovaEAgathocleousMMurphyMMHuZOxidative stress inhibits distant metastasis by human melanoma cellsNature2015527757718619126466563
  • BulcãoRPFreitasFAVenturiniCGAcute and subchronic toxicity evaluation of poly(epsilon-caprolactone) lipid-core nanocapsules in ratsToxicol Sci2013132116217623235194
  • FriedrichRBDimerFAGuterresSSBeckRCPohlmannARNano-encapsulation of tacrolimus in lipid-core nanocapsules showed similar immunosuppressive activity after oral and intraperitoneal administrationsJ Biomed Nanotechnol20141081599160925016659
  • RodriguesSFFielLAShimadaALBLipid-core nanocapsules act as a drug shuttle through the blood brain barrier and reduce glioblastoma after intravenous or oral administrationsJ Biomed Nanotechonol2016
  • CattaniVBFielLAJagerALipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirsEur J Pharm Sci2010391–311612419932749
  • GuterresSSFessiHBarrattGPuisieuxFDevissaguetJPPoly(D,L-lactide) nanocapsules containing non-steroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administrationPharm Res19951210154515478584497
  • TeixeiraMAlonsoMJPintoMMBarbosaCMDevelopment and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthoneEur J Pharm Biopharm200459349150015760730
  • LimaTMKanunfreCCPompéiaCVerlengiaRCuriRRanking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysisToxicol In Vitro200216674174712423658
  • CalderPCJensenGLKoletzkoBVSingerPWantenGJLipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directionsIntensive Care Med201036573574920072779
  • PradinesBBoriesCVauthierCPonchelGLoiseauPMBouchemalKDrug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosaPharm Res20153241229123625319099